-
Published 4/22/2025
Tilhou AS, Grucza RA, Xu KY. Substance-induced mental disorders and discontinuation of medication for opioid use disorder. Drug Alcohol Depend. 2025 Apr 22; 272:112685. PMID: 40319789.
-
Published 2/28/2025
Tilhou AS, Gasman S, Wang J, Standish K, White LF, Cogan A, Devlin M, Larochelle M, Adams WG. Assessing inequities in buprenorphine treatment across the care cascade. Drug Alcohol Depend. 2025 May 01; 270:112636. PMID: 40043350.
-
Published 5/17/2024
Tilhou A, Baldwin M, Alves J. No Time to Wait: Leveraging Primary Care to Treat Stimulant Use Disorder. Am J Prev Med. 2024 Sep; 67(3):464-469. PMID: 38762205.
-
Published 4/1/2024
Tilhou AS, Dague L, Chachlani P, Burns M. Can telehealth expansion boost health care utilization specifically for patients with substance use disorders relative to patients with other types of chronic disease? PLoS One. 2024; 19(4):e0299397. PMID: 38557607.
-
Published 3/17/2024
Tilhou AS, Burns M, Chachlani P, Chen Y, Dague L. How Does Telehealth Expansion Change Access to Healthcare for Patients With Different Types of Substance Use Disorders? Subst Use Addctn J. 2024 Jul; 45(3):473-485. PMID: 38494728.